Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex

Acta Neuropathologica

Volumn 100, Issue 6, 2000, Pages 608-617

  Thal, D R ^a   Schultz, Christian ^a   Dehghani, Faramarz ^a   Yamaguchi, Haruyasu ^b   Braak, Heiko ^a   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Amyloid protein precursor; Astrocytes; Fleecy amyloid

Indexed keywords

ALPHA SECRETASE; AMINO ACID; AMYLOID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; GLIAL FIBRILLARY ACIDIC PROTEIN; PEPTIDE; PROTEIN ANTIBODY;

ADULT; AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN TRANSPORT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTES; ENTORHINAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; SENILE PLAQUES;

EID: 0033774694     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000242     Document Type: Article

References (40)

1. Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein
2. Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease
3. An ultrastructural study of phagocytotic activity of astrocytes in adult rat brain
4. β-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
5. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
6. Neuropathological stageing of Alzheimer-related changes
7. The pathogenesis of senile plaques
8. Glial fibrillary acid protein and Alzheimer-type dementia
9. Ageing and dementia
10. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain
11. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution
12. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
13. Amyloid the presenilins and Alzheimer's disease
14. p3 β-amyloid peptide has a unique and potentially pathogenetic immunocytochemical profile in Alzheimer's disease brain
15. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
16. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
17. Silver labeling of Alzheimer neurofibrillary changes and brain β-amyloid
18. Full length amyloid-β (1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques
19. Early amyloid-β deposits show different immunoreactivity to the amino-and carboxy-terminal regions of β-peptide in Alzheimer's disease and Down's syndrome brain
20. LDL Receptor-related protein, a multifunctional Apo E receptor, binds secreted β-amyloid precursor protein and mediates its degradation
21. Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβ peptides of Alzheimer's disease
22. 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells
23. 2-macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein
24. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
25. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
26. 2macroglobulin receptor/low-density lipoprotein receptor related protein
27. Microglial activation in early stages of amyloid β protein deposition
28. The molecular pathology of Alzheimer's disease
29. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease
30. The cell biology of β-amyloid precursor proteinm and presenilin in Alzheimer's disease
31. Amyloid β protein (Aβ) removal by neuroglial cells in culture
32. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms
33. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits
34. Progression of neurofibrillary changes and PHF-τ; in end stage Alzheimer's disease is different from cortical plaque and microglial pathology
35. 8-17-immunoreactive deposits in subpial astrocytes
36. Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Aβ
37. 2-macroglobulin and interleukin 6 in Alzheimer's disease
38. Glial fibrillary acid protein is necessary for mature astrocytes to react to β-amyloid
39. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques
40. Disappearing senile plaques: Diffuse plaques with Aβ-granules in astrocytic secondary lysosomes